Datavant, a leading health data platform company, announces that it has signed an agreement to acquire Aetion, a leading real-world evidence (RWE) platform that powers critical decision-making in healthcare. With this acquisition, Aetion will join Datavant to deliver an end-to-end RWE platform, enabling healthcare and life sciences companies to more efficiently answer research questions about the clinical impact of therapies in development and in market. This complementary combination unites two leaders to make RWE truly actionable, covering the full spectrum of services needed to deliver scientifically validated, transparent and reproducible RWE accepted by global regulators, including the FDA and EMA.
Read the full article: Datavant to Acquire Aetion, Empowering Healthcare and Life Sciences Organizations to Generate High-Quality, Scalable Real-World Evidence from Connected, Privacy-Protected Data //
Source: https://www.businesswire.com/news/home/20250515882812/en/Datavant-to-Acquire-Aetion-Empowering-Healthcare-and-Life-Sciences-Organizations-to-Generate-High-Quality-Scalable-Real-World-Evidence-from-Connected-Privacy-Protected-Data